{"id":"W3116093824","doi":"10.1016/j.lungcan.2020.12.026","title":"Definitions, outcomes, and management of hyperprogression in patients with non-small-cell lung cancer treated with immune checkpoint inhibitors","year":2020,"lang":"en","type":"article","venue":"Lung Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Takeda Canada; AstraZeneca France; Pfizer; British Microcirculation Society; Boehringer Ingelheim; AbbVie; Roche","keywords":"Medicine; Lung cancer; Incidence (geometry); Internal medicine; Cancer; Response Evaluation Criteria in Solid Tumors; Medical record; Oncology; Retrospective cohort study; Disease; Progressive disease","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005463338,0.0002095311,0.0003784609,0.00007562299,0.00004196128,0.00001066385,0.00005808258,0.0000596766,0.0001003937],"category_scores_gemma":[0.000001269967,0.0001365671,0.00005339685,0.0003857039,0.0000720439,0.00006034389,0.00003585314,0.0001296133,4.331017e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002090965,"about_ca_system_score_gemma":0.00009426574,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001383492,"about_ca_topic_score_gemma":0.0001658798,"domain_scores_codex":[0.9988883,0.00001736407,0.0003340645,0.0002989318,0.0002449325,0.0002164025],"domain_scores_gemma":[0.9994904,0.00001002799,0.000170477,0.0001729287,0.00006732784,0.00008883646],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.004776345,0.000207796,0.9867896,0.00136575,0.0004375933,0.00002166255,0.000475448,0.00001789873,0.001143642,0.000002857486,0.0001936598,0.004567739],"study_design_scores_gemma":[0.01547296,0.0004887024,0.9724773,0.003176956,0.0004524348,8.284753e-7,0.0001733955,0.0001869332,0.0071298,3.86046e-7,0.0002279131,0.0002124534],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.989028,0.008258328,0.0000136736,0.000910818,0.00005791393,0.001167122,0.00003722136,0.00002637399,0.0005005339],"genre_scores_gemma":[0.993877,0.004758012,0.0004735809,0.0003989728,0.00002442511,0.0002867852,0.00004142699,0.00003681783,0.00010299],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01431237,"threshold_uncertainty_score":0.5569045,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01077471963902486,"score_gpt":0.2519211103375862,"score_spread":0.2411463906985614,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}